The aldosterone-renin screening market is forecasted to grow from USD 574.8 million in 2025 to USD 1,109.7 million by 2035, at a CAGR of 6.8% during the forecast period. The aldosterone-renin ...

Lorundrostat shows promise in reducing blood pressure and proteinuria in patients with hypertension and chronic kidney ...

With its demonstrated clinical benefits and superior selectivity profile, SC0062 is positioned to potentially become a ...

Acute MI mortality has fallen, yet deaths from other diseases, including heart failure and hypertension, are on the rise.

While heart disease has been the leading cause of death in the U.S. for over a century, the past 50 years have seen a ...

Second BTD Recognition Highlights Compound's Potential as Next-Generation Broad-Spectrum Renal Therapy SHANGHAI, June 2 ...

The main physiologic function of albumin is to maintain colloid osmotic pressure. The recognition of many other physiologic functions, however, means that the clinical application of albumin has ...

On May 7, 2025, the American College of Rheumatology (ACR) released the full guideline for diagnosing, monitoring, and treating lupus nephritis (LN), which appeared in Arthritis & Rheumatology.

Abstract—We previously reported that thyroid hormone stimulates renin synthesis in vivo and in vitro. Here, we analyzed the 5′-flanking sequence of the human renin gene for promoter activity ...

Some common dietary supplements can increase blood pressure, especially if you have high blood pressure or heart problems ...

A phase 2 trial evaluated the efficacy and safety of lorundrostat in hypertensive patients with chronic kidney disease (CKD) and albuminuria.

A novel integrated molecular imaging approach enables precise localization and quantification of heart damage, as well as ...